Our 2014 approach to breakthrough invasive fungal infections

Georg Maschmeyer, Thomas F. Patterson

Producción científica: Articlerevisión exhaustiva

31 Citas (Scopus)

Resumen

Summary: Evidence-based clinical pathways to direct antifungal treatment options in patients with breakthrough fungal infections during current systemic antifungal therapy are not available. Nonetheless, for defined settings of such breakthrough infections approaches to management can be recommended based on clinical, epidemiological, pharmacological and in vitro susceptibility data.

Idioma originalEnglish (US)
Páginas (desde-hasta)645-651
Número de páginas7
PublicaciónMycoses
Volumen57
N.º11
DOI
EstadoPublished - nov 1 2014

ASJC Scopus subject areas

  • Infectious Diseases
  • Dermatology

Huella

Profundice en los temas de investigación de 'Our 2014 approach to breakthrough invasive fungal infections'. En conjunto forman una huella única.

Citar esto